Is CVE-2026-9844 in the CISA KEV catalog?

No. CVE-2026-9844 is not currently on the CISA Known Exploited Vulnerabilities list.

What is the CVSS severity of CVE-2026-9844?

CVE-2026-9844 has a CVSS v4 base score of 8.8 (HIGH).

What is the EPSS score for CVE-2026-9844?

CVE-2026-9844 has an EPSS score of 0.24% (15th percentile), estimating the probability of exploitation in the next 30 days.

CVE & CISA-KEV Catalog

CVE-2026-9844

HIGH

8.8

CVSS v4

NVD

Description

Use of default credentials vulnerability in Roche Diagnostics navify Digital Pathology (RabbitMQ Management interface modules) allows Default Usernames and Passwords. This issue affects navify Digital Pathology: from 2.0.0 before 2.4.1.

CWE-1392

CVSS v4 Vector

Exploitability

Attack VectorNetwork

Attack ComplexityLow

Privileges RequiredNone

User InteractionNone

Impact

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:H/VA:H/SC:L/SI:L/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:N/AU:Y/R:U/V:D/RE:M/U:Green

Exploit Intelligence

0.24%probability of exploitation in 30 days

15thpercentile

Low risk: more likely to be exploited than 15% of all known CVEs.

References

https://diagnostics.roche.com/global/en/legal/product-security-advisory.html

Find and fix vulnerabilities across your fleet

TridentStack Control continuously scans your Windows, macOS, and Linux fleet for known vulnerabilities, prioritizes them by severity and active exploitation, and patches them automatically.

Start free

This product uses NVD data but is not endorsed or certified by the NVD. EPSS scores courtesy of FIRST.org (https://www.first.org/epss). Source: CISA KEV Catalog. Data as of 2026-06-17.